Financhill
Back

Disc Medicine Quote, Financials, Valuation and Earnings

Buy
70

IRON
Disc Medicine

Last Price:
32.18
Seasonality Move:
8.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Disc Medicine Price Quote

$32.18

Disc Medicine Key Stats

Buy
70
Disc Medicine (IRON) is a Buy

Day range:
$31.44 - $32.48
52-week range:
$25.60 - $77.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.35%

Volume:
295.6K
Avg. volume:
359.9K
1-year change:
-5.49%
Market cap:
$795.5M
Revenue:
$0
EPS:
$-3.38

How Much Does Disc Medicine Make?

Data Unavailable

Is Disc Medicine Growing As A Company?

Data Unavailable

Disc Medicine Stock Price Performance

  • Did Disc Medicine Stock Go Up Last Month?
    Disc Medicine share price went up by 6.27% last month
  • Did IRON's Share Price Rise Over The Last Year?
    IRON share price fell by -5.49% over the past 1 year

What Is Disc Medicine 52-Week High & Low?

Disc Medicine Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Disc Medicine?

  • How Much Debt Does Disc Medicine Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Disc Medicine Have?
    Cash and short term investments quarterly total is $342.6M
  • What Is Disc Medicine’s Book Value Per Share?
    Book value per share is 13.69

Is Disc Medicine Cash Flow Positive?

  • What Is IRON Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.6M
  • What Is Disc Medicine’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $178M
  • What Is Disc Medicine’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$127K

Disc Medicine Return On Invested Capital

Data Unavailable

Disc Medicine Earnings Date & Stock Price

Disc Medicine Competitors

  • Who Are Disc Medicine's Competitors?
    Below is a list of companies who compete with Disc Medicine or are related in some way:
    • ACADIA Pharmaceuticals Inc (ACAD)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Marinus Pharmaceuticals Inc (MRNS)
    • Rocket Pharmaceuticals Inc (RCKT)
    • Regenxbio Inc (RGNX)

Disc Medicine Dividend Yield

Data Unavailable

Disc Medicine Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -10.26%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 57.33
Upside from Last Price: 78.16%

Major Shareholders

  • How many IRON shares are owned by institutional investors?
    30.4M IRON shares are owned by institutional investors
  • How many IRON shares are owned by insiders?
    652K IRON shares are owned by insiders